Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Attendo ABCHIX:ATTS 68 EV-to-EBITDA is 7.94 as of Jul. 28, 2026, which is 9% below its 10-year median of 8.72. GuruFocus rates CHIX:ATTS with a GF Score™ of 68/100 and a GF Value™ of kr55.06 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Attendo AB ranks better than 66.21% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Attendo AB's enterprise value is kr30,879 Mil.
Attendo AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr3,888 Mil. Therefore, Attendo AB's EV-to-EBITDA for today is 7.94.
The historical rank and industry rank for Attendo AB's EV-to-EBITDA or its related term are showing as below:
CHIX:ATTs'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.51 Med: 8.72 Max: 21.41
Current: 7.94
During the past 13 years, the highest EV-to-EBITDA of Attendo AB was 21.41. The lowest was 6.51. And the median was 8.72.
CHIX:ATTs's EV-to-EBITDA is ranked better than 66.21% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.03
vs CHIX:ATTs: 7.94
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Attendo AB (CHIX:ATTs) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Attendo AB's share price for today is kr114.65.
Attendo AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr5.900.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Attendo AB's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:ATTS vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Attendo AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Attendo AB EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Attendo AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Attendo AB's EV-to-EBITDA falls into.
Attendo AB's current Enterprise Value is kr30,879 Mil.
Attendo AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3,888 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Attendo AB (CHIX:ATTS) has a EV-to-EBITDA of 7.94 as of Jul. 28, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Attendo AB. This is near median its historical median of 8.72. Over the past decade, Attendo AB's EV-to-EBITDA has ranged from 6.51 to 21.41. According to the industry distribution chart, Attendo AB ranks #172 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 33.8%.
Is Attendo AB's EV-to-EBITDA too high?
Attendo AB's current EV-to-EBITDA of 7.94 is near median its 10-year median of 8.72. Over the past 10 years, this metric has ranged from a low of 6.51 to a high of 21.41. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.03. Attendo AB's value of 7.94 is 28% below this industry median. Based on the distribution chart, Attendo AB ranks #172 out of 509 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Attendo AB has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Attendo AB's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Attendo AB ranks #172 out of 509 companies for EV-to-EBITDA. This puts Attendo AB in the upper half of its industry. The industry median EV-to-EBITDA is 11.03. Attendo AB's value of 7.94 is 28% below this benchmark. Historically, Attendo AB's own EV-to-EBITDA has ranged from 6.51 to 21.41 over the past decade. While the company's 10-year median is 8.72 vs. the industry median of 11.03, Attendo AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.03, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Attendo AB's current EV-to-EBITDA of 7.94 is 28% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Attendo AB. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Attendo AB's current EV-to-EBITDA is 7.94, which is near median its own 10-year median of 8.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Attendo AB stock overvalued right now?
Based on GuruFocus' analysis, Attendo AB (CHIX:ATTS) is currently considered Significantly Overvalued. The stock's GF Value™ is kr55.06, compared to a current price of kr114.65 — trading 108.2% above its estimated fair value. The current EV-to-EBITDA is 7.94, which is near median its 10-year median of 8.72 and 28% below the Healthcare Providers & Services industry median of 11.03. Attendo AB's overall GF Score™ is 68/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Attendo AB (CHIX:ATTS), the current EV-to-EBITDA is 7.94 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Attendo AB (CHIX:ATTS) Overvalued in 2026?
Based on GuruFocus' analysis, Attendo AB stock appears to be overvalued.
The current stock price of kr114.65 is trading 108.2% above its estimated GF Value™ of kr55.06.
GuruFocus considers Attendo AB to be Significantly Overvalued.
Key valuation signals for CHIX:ATTS:
EV-to-EBITDA: 7.94 (near median its 10-year median of 8.72)
GF Value™: kr55.06 vs. price of kr114.65 (108.2% above fair value)
Industry Position: 28% below the Healthcare Providers & Services median (#172 of 509)
No single metric tells the full story. See the CHIX:ATTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Attendo AB is a company that is engaged in providing private care and healthcare services in the Nordics. It focuses on offering care for older people, care for people with disabilities, individual and family care, and health care. The company also offers health, medical, and as well as staffing services. Geographically, the group's majority revenue is generated from Finland, it also operates in Scandinavia countries.
68GF Score
Get the complete analysis for CHIX:ATTS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ATTS has been successfully added to your 
